In vitro immune response of SLE lymphocytes. The mechanism involved in B-cell activation

Tsutomu Takeuchi, T. Abe, M. Kiyotaki, T. Toguchi, J. Koide, C. Morimoto, M. Homma

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Peripheral blood lymphocytes from 26 patients with systemic lupus erythematosus (SLE) and six normal individuals were tested for IgG synthesis in the presence or absence of PWM. Lymphocytes from patients with active SLE synthesized increased amounts of IgG in the absence of PWM and reduced amounts of IgG in the presence of PWM. Serum from patients with active SLE had an enhancing effect on the in vitro IgG synthesis of normal lymphocytes. The IgG or F(ab')2 fractions of SLE serum retained the enhancing effect on in vitro IgG synthesis, and the enhancing activity was absorbed by human spleen cells. As little as 4 h of incubation with SLE serum was needed for the enhancing activity of normal lymphocytes. Treatment of B lymphocytes appeared to be of main importance for an increase in the in vitro IgG synthesis of SLE serum-treated lymphocytes. These results suggest that anti-B-lymphocyte antibodies from patients with active SLE are responsible in part for the hyperactive response of SLE B lymphocytes.

Original languageEnglish
Pages (from-to)369-377
Number of pages9
JournalScandinavian Journal of Immunology
Volume16
Issue number5
DOIs
Publication statusPublished - 1982

Fingerprint

Systemic Lupus Erythematosus
B-Lymphocytes
Lymphocytes
Immunoglobulin G
Serum
In Vitro Techniques
Spleen
Antibodies

ASJC Scopus subject areas

  • Immunology

Cite this

In vitro immune response of SLE lymphocytes. The mechanism involved in B-cell activation. / Takeuchi, Tsutomu; Abe, T.; Kiyotaki, M.; Toguchi, T.; Koide, J.; Morimoto, C.; Homma, M.

In: Scandinavian Journal of Immunology, Vol. 16, No. 5, 1982, p. 369-377.

Research output: Contribution to journalArticle

Takeuchi, Tsutomu ; Abe, T. ; Kiyotaki, M. ; Toguchi, T. ; Koide, J. ; Morimoto, C. ; Homma, M. / In vitro immune response of SLE lymphocytes. The mechanism involved in B-cell activation. In: Scandinavian Journal of Immunology. 1982 ; Vol. 16, No. 5. pp. 369-377.
@article{90310c73ad0f4b31b309ddbdbd2344f4,
title = "In vitro immune response of SLE lymphocytes. The mechanism involved in B-cell activation",
abstract = "Peripheral blood lymphocytes from 26 patients with systemic lupus erythematosus (SLE) and six normal individuals were tested for IgG synthesis in the presence or absence of PWM. Lymphocytes from patients with active SLE synthesized increased amounts of IgG in the absence of PWM and reduced amounts of IgG in the presence of PWM. Serum from patients with active SLE had an enhancing effect on the in vitro IgG synthesis of normal lymphocytes. The IgG or F(ab')2 fractions of SLE serum retained the enhancing effect on in vitro IgG synthesis, and the enhancing activity was absorbed by human spleen cells. As little as 4 h of incubation with SLE serum was needed for the enhancing activity of normal lymphocytes. Treatment of B lymphocytes appeared to be of main importance for an increase in the in vitro IgG synthesis of SLE serum-treated lymphocytes. These results suggest that anti-B-lymphocyte antibodies from patients with active SLE are responsible in part for the hyperactive response of SLE B lymphocytes.",
author = "Tsutomu Takeuchi and T. Abe and M. Kiyotaki and T. Toguchi and J. Koide and C. Morimoto and M. Homma",
year = "1982",
doi = "10.1111/j.1365-3083.1982.tb00737.x",
language = "English",
volume = "16",
pages = "369--377",
journal = "Scandinavian Journal of Immunology",
issn = "0300-9475",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - In vitro immune response of SLE lymphocytes. The mechanism involved in B-cell activation

AU - Takeuchi, Tsutomu

AU - Abe, T.

AU - Kiyotaki, M.

AU - Toguchi, T.

AU - Koide, J.

AU - Morimoto, C.

AU - Homma, M.

PY - 1982

Y1 - 1982

N2 - Peripheral blood lymphocytes from 26 patients with systemic lupus erythematosus (SLE) and six normal individuals were tested for IgG synthesis in the presence or absence of PWM. Lymphocytes from patients with active SLE synthesized increased amounts of IgG in the absence of PWM and reduced amounts of IgG in the presence of PWM. Serum from patients with active SLE had an enhancing effect on the in vitro IgG synthesis of normal lymphocytes. The IgG or F(ab')2 fractions of SLE serum retained the enhancing effect on in vitro IgG synthesis, and the enhancing activity was absorbed by human spleen cells. As little as 4 h of incubation with SLE serum was needed for the enhancing activity of normal lymphocytes. Treatment of B lymphocytes appeared to be of main importance for an increase in the in vitro IgG synthesis of SLE serum-treated lymphocytes. These results suggest that anti-B-lymphocyte antibodies from patients with active SLE are responsible in part for the hyperactive response of SLE B lymphocytes.

AB - Peripheral blood lymphocytes from 26 patients with systemic lupus erythematosus (SLE) and six normal individuals were tested for IgG synthesis in the presence or absence of PWM. Lymphocytes from patients with active SLE synthesized increased amounts of IgG in the absence of PWM and reduced amounts of IgG in the presence of PWM. Serum from patients with active SLE had an enhancing effect on the in vitro IgG synthesis of normal lymphocytes. The IgG or F(ab')2 fractions of SLE serum retained the enhancing effect on in vitro IgG synthesis, and the enhancing activity was absorbed by human spleen cells. As little as 4 h of incubation with SLE serum was needed for the enhancing activity of normal lymphocytes. Treatment of B lymphocytes appeared to be of main importance for an increase in the in vitro IgG synthesis of SLE serum-treated lymphocytes. These results suggest that anti-B-lymphocyte antibodies from patients with active SLE are responsible in part for the hyperactive response of SLE B lymphocytes.

UR - http://www.scopus.com/inward/record.url?scp=0020467686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020467686&partnerID=8YFLogxK

U2 - 10.1111/j.1365-3083.1982.tb00737.x

DO - 10.1111/j.1365-3083.1982.tb00737.x

M3 - Article

C2 - 6758109

AN - SCOPUS:0020467686

VL - 16

SP - 369

EP - 377

JO - Scandinavian Journal of Immunology

JF - Scandinavian Journal of Immunology

SN - 0300-9475

IS - 5

ER -